Ganglioside modulation of CD4 does not block T-helper cell function as compared to antagonism by anti-CD4 antibody

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Gangliosides (GM1) modulate CD4 from the surface of T-helper lymphocytes and have been shown to block CD4-mediated HIV-1 infection in vitro. However, the effects of GM1 on CD4 are neutralized in the presence of serum. We sought to make a GM1 derivative which would resist serum neutralization and to determine whether modulation of CD4 by GM1 would affect T-helper lymphocyte function. Study of GM1 and GM1-derivatives in the presence of serum indicated that the active conformation involves intact sialic acid hydroxyl groups and intermolecular ganglioside interactions. All chemical modifications directed toward the sialic acid moiety reduced the ability of GM1 to modulate CD4. Elution profiles of GM1 in the presence and absence of albumin indicate that the active form of GM1 is represented by micelles that are disrupted by albumin. Function studies show that CD4 T-helper cells made CD- by GM1 treatment continue to proliferate in culture and recognize antigen (Ag) through the T cell receptor (TcR). Moreover, T-helper cell mediated inflammation assessed by Ag-specific, delayed type hypersensitivity (DTH) was enhanced after passive transfer of GM1-treated T-helper cells to naive animals. In comparison, CD4 blockade by anti-CD4 antibody decreased Ag-stimulated T-helper cell proliferation and DTH reactions. These results demonstrate that 1) CD4 modulation involves an active conformation that arises from sialic acid effector molecules organized by micellar GM1 conformations; and 2) the mechanism by which GM1 modulates CD4 is different from CD4 antagonism seen with anti-CD4 antibody treatment.

Original languageEnglish (US)
Pages (from-to)315-323
Number of pages9
JournalDrug Development Research
Volume25
Issue number4
StatePublished - 1992

Fingerprint

Gangliosides
N-Acetylneuraminic Acid
Helper-Inducer T-Lymphocytes
Conformations
Anti-Idiotypic Antibodies
Lymphocytes
Modulation
Antigens
Antibodies
Albumins
Derivatives
G(M1) Ganglioside
Delayed Hypersensitivity
Chemical modification
Cell proliferation
Micelles
T-Cell Antigen Receptor
Hydroxyl Radical
Serum
Animals

Keywords

  • CD4 molecule
  • Gangliosides
  • T-helper cells

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

@article{06c387900f72408eafaf672acaecd654,
title = "Ganglioside modulation of CD4 does not block T-helper cell function as compared to antagonism by anti-CD4 antibody",
abstract = "Gangliosides (GM1) modulate CD4 from the surface of T-helper lymphocytes and have been shown to block CD4-mediated HIV-1 infection in vitro. However, the effects of GM1 on CD4 are neutralized in the presence of serum. We sought to make a GM1 derivative which would resist serum neutralization and to determine whether modulation of CD4 by GM1 would affect T-helper lymphocyte function. Study of GM1 and GM1-derivatives in the presence of serum indicated that the active conformation involves intact sialic acid hydroxyl groups and intermolecular ganglioside interactions. All chemical modifications directed toward the sialic acid moiety reduced the ability of GM1 to modulate CD4. Elution profiles of GM1 in the presence and absence of albumin indicate that the active form of GM1 is represented by micelles that are disrupted by albumin. Function studies show that CD4 T-helper cells made CD- by GM1 treatment continue to proliferate in culture and recognize antigen (Ag) through the T cell receptor (TcR). Moreover, T-helper cell mediated inflammation assessed by Ag-specific, delayed type hypersensitivity (DTH) was enhanced after passive transfer of GM1-treated T-helper cells to naive animals. In comparison, CD4 blockade by anti-CD4 antibody decreased Ag-stimulated T-helper cell proliferation and DTH reactions. These results demonstrate that 1) CD4 modulation involves an active conformation that arises from sialic acid effector molecules organized by micellar GM1 conformations; and 2) the mechanism by which GM1 modulates CD4 is different from CD4 antagonism seen with anti-CD4 antibody treatment.",
keywords = "CD4 molecule, Gangliosides, T-helper cells",
author = "Morrison, {W. J.} and Halina Offner and Arthur Vandenbark",
year = "1992",
language = "English (US)",
volume = "25",
pages = "315--323",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Ganglioside modulation of CD4 does not block T-helper cell function as compared to antagonism by anti-CD4 antibody

AU - Morrison, W. J.

AU - Offner, Halina

AU - Vandenbark, Arthur

PY - 1992

Y1 - 1992

N2 - Gangliosides (GM1) modulate CD4 from the surface of T-helper lymphocytes and have been shown to block CD4-mediated HIV-1 infection in vitro. However, the effects of GM1 on CD4 are neutralized in the presence of serum. We sought to make a GM1 derivative which would resist serum neutralization and to determine whether modulation of CD4 by GM1 would affect T-helper lymphocyte function. Study of GM1 and GM1-derivatives in the presence of serum indicated that the active conformation involves intact sialic acid hydroxyl groups and intermolecular ganglioside interactions. All chemical modifications directed toward the sialic acid moiety reduced the ability of GM1 to modulate CD4. Elution profiles of GM1 in the presence and absence of albumin indicate that the active form of GM1 is represented by micelles that are disrupted by albumin. Function studies show that CD4 T-helper cells made CD- by GM1 treatment continue to proliferate in culture and recognize antigen (Ag) through the T cell receptor (TcR). Moreover, T-helper cell mediated inflammation assessed by Ag-specific, delayed type hypersensitivity (DTH) was enhanced after passive transfer of GM1-treated T-helper cells to naive animals. In comparison, CD4 blockade by anti-CD4 antibody decreased Ag-stimulated T-helper cell proliferation and DTH reactions. These results demonstrate that 1) CD4 modulation involves an active conformation that arises from sialic acid effector molecules organized by micellar GM1 conformations; and 2) the mechanism by which GM1 modulates CD4 is different from CD4 antagonism seen with anti-CD4 antibody treatment.

AB - Gangliosides (GM1) modulate CD4 from the surface of T-helper lymphocytes and have been shown to block CD4-mediated HIV-1 infection in vitro. However, the effects of GM1 on CD4 are neutralized in the presence of serum. We sought to make a GM1 derivative which would resist serum neutralization and to determine whether modulation of CD4 by GM1 would affect T-helper lymphocyte function. Study of GM1 and GM1-derivatives in the presence of serum indicated that the active conformation involves intact sialic acid hydroxyl groups and intermolecular ganglioside interactions. All chemical modifications directed toward the sialic acid moiety reduced the ability of GM1 to modulate CD4. Elution profiles of GM1 in the presence and absence of albumin indicate that the active form of GM1 is represented by micelles that are disrupted by albumin. Function studies show that CD4 T-helper cells made CD- by GM1 treatment continue to proliferate in culture and recognize antigen (Ag) through the T cell receptor (TcR). Moreover, T-helper cell mediated inflammation assessed by Ag-specific, delayed type hypersensitivity (DTH) was enhanced after passive transfer of GM1-treated T-helper cells to naive animals. In comparison, CD4 blockade by anti-CD4 antibody decreased Ag-stimulated T-helper cell proliferation and DTH reactions. These results demonstrate that 1) CD4 modulation involves an active conformation that arises from sialic acid effector molecules organized by micellar GM1 conformations; and 2) the mechanism by which GM1 modulates CD4 is different from CD4 antagonism seen with anti-CD4 antibody treatment.

KW - CD4 molecule

KW - Gangliosides

KW - T-helper cells

UR - http://www.scopus.com/inward/record.url?scp=0026588962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026588962&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0026588962

VL - 25

SP - 315

EP - 323

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 4

ER -